| Catalog Number |
305271 |
| Medical Device Problem Code |
Break (1069)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
11/01/2023
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
E.4.The initial reporter also notified the fda on 09jan2924).Medwatch report is (b)(4).H.3.If a device evaluation and/or device history review is completed, a supplemental report will be filed.
|
| |
|
Event or Problem Description
|
|
It was reported that the bd integra needle was defective.The following information was provided by the initial reporter: "a nurse using safety catheter when utilizing the push button the needle retracted but the whole device broke apart.Bd integra syringe 3ml 23g x 1 im needle (lot 2271484) used for im toradol administration.Medication drawn up into syringe, im injection preformed on patient, safety push on plunger initiated and needle did not retract into syringe.Plunger did engage and depress but the needle did not retract.Similar reports seen in maude database.".
|
| |
|
Event or Problem Description
|
|
No additional information.
|
| |
|
Additional Manufacturer Narrative
|
|
Pr 9513197 ¿ follow up mdr for device evaluation.Since no samples displaying the condition reported are available for examination, we were unable to fully investigate this incident.No root cause can be determined as no samples were received.Furthermore, a device history record review showed no rejected inspections or quality issues during the production of the provided lot number that could have contributed to the reported defect.We would be very interested in examining product that does not meet your expectations and our quality standards.Should you again experience any problems with our product we would appreciate the opportunity to conduct a thorough analysis.Examination of the product involved may provide clarification as to the cause for the reported failure.We appreciate you taking the time to bring this observation to our attention.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored monthly.Our business team regularly reviews the collected data for identification of emerging trends.
|
| |
|
Additional Manufacturer Narrative
|
|
Becton dickinson and company's (bd) medication delivery solutions (mds) business unit will discontinue malfunction mdr reporting for certain device failures that have not caused or contributed to deaths or serious injuries in the past two years, and where the likelihood of a death or serious injury as a result of these malfunctions is remote.This decision follows fda guidelines (medical device reporting for manufacturers guidance for industry and food and drug administration staff issued nov 8, 2016, reference section 2.15).Bd notified fda of this decision on mar 3, 2025.Fda has reviewed and responded to bd¿s notification (reference fda document#: (b)(4)) on march 7, 2025.This documentation is available in bd document management system (sap) as dir (b)(4).This supplemental mdr is being filed to document that the below device failure will no longer be considered a reportable malfunction mdr for the product family below: product family: integra.Device failure: needle damaged / defective.
|
| |
|
Event or Problem Description
|
|
No additional information.
|
| |
|
Search Alerts/Recalls
|